# Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/overall-survival-with-osimertinib-in-untreated-egfr-mutated-advanced-nsclc/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Suresh S. Ramalingam,Johan Vansteenkiste,David Planchard,Byoung Chul Cho,Jhanelle E Gray,Yuichiro Ohe,Caicun Zhou,Thanyanan Reungwetwattana,Y Cheng,Busyamas Chewaskulyong,R. Shah,Manuel Cobo,Ki Hyeong Lee,Parneet Cheema,Marcello Tiseo,Thomas John,Meng-Chih Lin,Fumio Imamura,Takayasu Kurata,Alexander Todd,Rachel Hodge,Matilde Saggese,Yuri Rukazenkov,Jean‐Charles Soria,FLAURA Investigators |
| Citations | 287 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W6967040437 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Marcello Tiseo](https://scholariq.org/researchers/marcello-tiseo/)

## Paper journal

- [Open MIND](https://scholariq.org/journals/open-mind/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.